Literature DB >> 24368934

Endoscopic mucosal resection of Barrett's esophagus detects high prevalence of subsquamous intestinal metaplasia.

Patrick Yachimski1, Chanjuan Shi1, James C Slaughter1, Mary Kay Washington1.   

Abstract

AIM: To report the prevalence of Subsquamous intestinal metaplasia (SSIM) in patients undergoing endoscopic mucosal resection (EMR) for staging of Barrett's esophagus (BE).
METHODS: Thirty-three patients with BE associated neoplasia underwent EMR at our institution between September 2009 and September 2011; 22 of these patients met study inclusion criteria. EMR was targeted at focal abnormalities within the BE segment. EMR was performed in standardized fashion using a cap-assisted band ligation technique, and resection specimens were assessed for the presence of SSIM. Demographic and clinical data were analyzed to determine predictors of SSIM.
RESULTS: SSIM was detected in 59% of patients. SSIM was detected in 73% of patients with short segment (< 3 cm) BE, and in 45% of patients with long-segment (≥ 3 cm) BE (P = NS). There was no association between presence/absence of SSIM and age, gender, or stage of BE-associated neoplasia.
CONCLUSION: EMR detects SSIM in a majority of patients with BE-associated neoplasia. While the long-term clinical significance of SSIM remains uncertain, these results highlight the importance of EMR as an optimal diagnostic tool for staging of BE and detection of SSIM, and should further limit concerns that SSIM is purely a post-ablation phenomenon.

Entities:  

Keywords:  Barrett epithelium; Barrett esophagus; Endoscopy; Esophageal cancer; Pathology

Year:  2013        PMID: 24368934      PMCID: PMC3870912          DOI: 10.4253/wjge.v5.i12.590

Source DB:  PubMed          Journal:  World J Gastrointest Endosc


  21 in total

1.  Properties of the neosquamous epithelium after radiofrequency ablation of Barrett's esophagus containing neoplasia.

Authors:  Roos E Pouw; Joep J Gondrie; Agnieszka M Rygiel; Carine M Sondermeijer; Fiebo J ten Kate; Robert D Odze; Michael Vieth; Kausilia K Krishnadath; Jacques J Bergman
Journal:  Am J Gastroenterol       Date:  2009-04-21       Impact factor: 10.864

2.  Durability of radiofrequency ablation in Barrett's esophagus with dysplasia.

Authors:  Nicholas J Shaheen; Bergein F Overholt; Richard E Sampliner; Herbert C Wolfsen; Kenneth K Wang; David E Fleischer; Virender K Sharma; Glenn M Eisen; M Brian Fennerty; John G Hunter; Mary P Bronner; John R Goldblum; Ana E Bennett; Hiroshi Mashimo; Richard I Rothstein; Stuart R Gordon; Steven A Edmundowicz; Ryan D Madanick; Anne F Peery; V Raman Muthusamy; Kenneth J Chang; Michael B Kimmey; Stuart J Spechler; Ali A Siddiqui; Rhonda F Souza; Anthony Infantolino; John A Dumot; Gary W Falk; Joseph A Galanko; Blair A Jobe; Robert H Hawes; Brenda J Hoffman; Prateek Sharma; Amitabh Chak; Charles J Lightdale
Journal:  Gastroenterology       Date:  2011-05-06       Impact factor: 22.682

3.  Adequacy of esophageal squamous mucosa specimens obtained during endoscopy: are standard biopsies sufficient for postablation surveillance in Barrett's esophagus?

Authors:  Neil Gupta; Sharad C Mathur; John A Dumot; Vikas Singh; Srinivas Gaddam; Sachin B Wani; Ajay Bansal; Amit Rastogi; John R Goldblum; Prateek Sharma
Journal:  Gastrointest Endosc       Date:  2011-09-10       Impact factor: 9.427

4.  Endoscopic radiofrequency ablation for Barrett's esophagus: 5-year outcomes from a prospective multicenter trial.

Authors:  D E Fleischer; B F Overholt; V K Sharma; A Reymunde; M B Kimmey; R Chuttani; K J Chang; R Muthasamy; C J Lightdale; N Santiago; D K Pleskow; P J Dean; K K Wang
Journal:  Endoscopy       Date:  2010-09-20       Impact factor: 10.093

Review 5.  Barrett's esophagus.

Authors:  Gary W Falk
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

Review 6.  Subsquamous intestinal metaplasia: implications for endoscopic management of Barrett's esophagus.

Authors:  Patrick Yachimski; Gary W Falk
Journal:  Clin Gastroenterol Hepatol       Date:  2011-10-20       Impact factor: 11.382

7.  Expert pathology review and endoscopic mucosal resection alters the diagnosis of patients referred to undergo therapy for Barrett's esophagus.

Authors:  Katie Ayers; Chanjuan Shi; Kay Washington; Patrick Yachimski
Journal:  Surg Endosc       Date:  2013-02-07       Impact factor: 4.584

8.  Comprehensive microscopy of the esophagus in human patients with optical frequency domain imaging.

Authors:  Melissa J Suter; Benjamin J Vakoc; Patrick S Yachimski; Milen Shishkov; Gregory Y Lauwers; Mari Mino-Kenudson; Brett E Bouma; Norman S Nishioka; Guillermo J Tearney
Journal:  Gastrointest Endosc       Date:  2008-10       Impact factor: 9.427

9.  Radiofrequency ablation in Barrett's esophagus with dysplasia.

Authors:  Nicholas J Shaheen; Prateek Sharma; Bergein F Overholt; Herbert C Wolfsen; Richard E Sampliner; Kenneth K Wang; Joseph A Galanko; Mary P Bronner; John R Goldblum; Ana E Bennett; Blair A Jobe; Glenn M Eisen; M Brian Fennerty; John G Hunter; David E Fleischer; Virender K Sharma; Robert H Hawes; Brenda J Hoffman; Richard I Rothstein; Stuart R Gordon; Hiroshi Mashimo; Kenneth J Chang; V Raman Muthusamy; Steven A Edmundowicz; Stuart J Spechler; Ali A Siddiqui; Rhonda F Souza; Anthony Infantolino; Gary W Falk; Michael B Kimmey; Ryan D Madanick; Amitabh Chak; Charles J Lightdale
Journal:  N Engl J Med       Date:  2009-05-28       Impact factor: 91.245

10.  Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.

Authors:  Jennifer Chennat; Andrew S Ross; Vani J A Konda; Shang Lin; Amy Noffsinger; John Hart; Irving Waxman
Journal:  Gastrointest Endosc       Date:  2009-06-24       Impact factor: 9.427

View more
  1 in total

1.  Evaluation Through the Optical Coherence Tomography Analysis of the Influence of Non-Alcoholic Fatty Liver Disease on the Gingival Inflammation in Periodontal Patients.

Authors:  Petra Surlin; Andreea Cristiana Didilescu; Luminita Lazar; Dorin Nicolae Gheorghe; Cristian Cosmin Arsenie; Adrian Camen; Dora Maria Popescu; Eugen Osiac; Ion Rogoveanu
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-29       Impact factor: 3.168

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.